SPRINTR launches a consent solution

SPRINTR launches a consent solution

The digital solution enables a reliable, simple, and secure way for study participants to provide informed consent-regardless of when or where they are. The SPRINTR project has also received ALF infrastructure funding so that the e-consent solution can be adapted for and used by more research projects.

The implementation of e-consent is a key part of the SPRINTR study's efforts to reduce administrative burden, strengthen data quality, and create more accessible pathways into research for men being evaluated for, or diagnosed with, prostate cancer. It is the first step toward building functional digital tools into a full infrastructure for future precision medicine studies.

- With the Swedish Prostate Cancer Association represented on both SPRINTR's steering committee and advisory board, it is particularly pleasing that the association's chair, Magnus Klang, was the first to sign using the new e-consent solution, says Andreas Josefsson, SPRINTR's principal investigator.

It is, of course, a milestone that symbolises both trust and commitment on the part of the patient organisation to this project.

With the e-consent solution now in place, SPRINTR is even better positioned to continue its mission: to create a nationally coordinated, innovative, and patient-centred research platform to improve survival and quality of life for men with prostate cancer.